However, it may also cause the darkening of existing moles or the appearance of new ones, raising concerns about skin health monitoring
Two options are approved: Wegovy (weekly) and Saxenda (daily)
En esta revisin se analizarn los nuevos frmacos con efecto incretina, los agonistas del pptido similar al glucagn tipo 1 (AR-GLP1) e inhibidores de la dipeptidil peptidasa 4 (IDPP-4), y los inhibidores de los cotransportadores sodio-glucosa tipo 2 (ISLGT2) que aumentan la excrecin renal de glucosa
The websites content is not intended to recommend or endorse any specific tests, physicians, procedures, opinions, or other information that may be mentioned on the site
[DOI] [PubMed] [Google Scholar] [98].Husain M, Birkenfeld AL, Donsmark M, et al